(11-027) Comparison of Low and High Dose Four-Factor Prothrombin Complex Concentrate vs Andexanet Alfa for the Reversal of Factor-Xa-Inhibitor-Associated Bleeding: A Retrospective Multicenter Cohort Study

Wednesday, December 7, 2022

12:30 PM – 1:30 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Emergency Medicine

Co-Author(s): Jonathan Mitchell, Taylor Money-Williams, Judson Stoltz

Primary Author(s)

Spencer A. Harris, PharmD
Resident Pharmacist
Baptist Memorial Healthcare, Mississippi